A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis

By Gonzalo R.M.   del Real G.   Rodriguez J.R.   Rodriguez D.   Heljasvaara R.   Lucas P.   Larraga V.   Esteban M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1226-1231

Elsevier

Access to resources Recommend Favorite

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

By Moorthy V.S.   McConkey S.   Roberts M.   Gothard P.   Arulanantham N.   Degano P.   Schneider J.   Hannan C.   Roy M.   Gilbert S.C.   Peto T.E.A.   Hill A.V.S.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2004-2011

Elsevier

Access to resources Recommend Favorite

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme

By Huemer H.P.   Strobl B.   Nowotny N.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1320-1326

Elsevier

Access to resources Recommend Favorite

Associations between RAS Gene Polymorphisms, Environmental Factors and Hypertension in Mongolian People

By Gui-yan Wang   Yan-hua Wang   Qun Xu   Wei-jun Tong   Ming-ling Gu   Jian Wang   Ming-wu Fang   Yong-hong Zhang  

European Journal of Epidemiology, Vol. 21, Iss. 4, 2006-04 ,pp. : 287-292

Springer Publishing Company

Access to resources Recommend Favorite

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

By Degano P.   Schneider J.   Hannan C.M.   Gilbert S.C.   Hill A.V.S.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 623-632

Elsevier

Access to resources Recommend Favorite